Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Lupica
Definicin
Nefritis
lpica (NL):
Sistmico (LES).
Constituye uno de los ms importantes
Introduccin
En
La
Los
Clinical features of SLE. In: Textbook of Rheumatology, Kelley, WN, et al (Eds), WB Saunders, Philadelphia 2000.
Epidemiologa
La
En
Seligman VA, Lum RF, Olson JL, et al. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J
Epidemiologa
El
La
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Epidemiologa
En
La
Seligman VA, Lum RF, Olson JL, et al. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J
Fisiopatogenia
Los
Tambin
Los
El
Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies form the glomerular immune deposits in
patients with systemic lupus erythematosus. J Rheumatol 2003; 30:1495.
Fisiopatogenia
Complejos
Los
Algunos
Horvth L, Czirjk L, Fekete B, et al. High levels of antibodies against Clq are associated with disease activity and nephritis but
not with other organ manifestations in SLE patients. Clin Exp Rheumatol 2001; 19:667
Fisiopatogenia
Estudios
Hasta
el momento no se ha podido
determinar con certeza la causa de
la predisposicin al desarrollo de LES
en poblaciones de etnia negra.
Karassa FB, Trikalinos TA, Ioannidis JP, Fc gamma RIIIA-SLE meta-analysis investigators. The Fc gamma RIIIA-F158 allele is a risk factor
for the development of lupus nephritis: a meta-analysis. Kidney Int 2003; 63:1475.
Clasificacin
El
Publicado
Jan J. Weening MD et al.; The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited; ASNFebruary 1,
2004vol. 15no. 2241-250
Clasificacin
McCluske RT: Lupus nephritis. In: Kidney Pathology Decennial 19661975,edited by Sommer SC, East Norwalk CT,
Appleton-Century-Crofts, 1975, pp 435450
Clasificacin
En
Esta
Se
Jan J. Weening MD et al.; The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited; ASNFebruary 1,
2004vol. 15no. 2241-250
Clasificacin
Jan J. Weening MD et al.; The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited; ASNFebruary 1,
2004vol. 15no. 2241-250
Clasificacin
Para
Esta
Su
Jan J. Weening MD et al.; The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited; ASNFebruary 1,
2004vol. 15no. 2241-250
Clasificacin
Clasificacin
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Los
La
No
El
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Otros
El
El
Schwartz MM, Kawala KS, Corwin HL, Lewis EJ. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus.
Clasificacin
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Burthon R. MD et al. Types of renal disease in systemic lupus erythematosus;UpToDate 19.3; Last Review Fri Sep 30 2011.
Clasificacin
Rich SA. De novo synthesis and secretion of a 36-kD protein by cells that form lupus inclusions in response to alpha-
Clasificacin
Ferluga D, Jerse M, Vizjak A, Hvala A, Rozman B, Kos-Golja M, Bren AF. Correlation among WHO classes,
histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
Clasificacin
Tron F, Ganeval D, Droz D. Immunologically-mediated acute renal failure of nonglomerular origin in the course of systemic lupus
erythematosus [SLE]. Report of two cases. Am J Med 1979; 67:529.
Clasificacin
Gelfand J, Truong L, Stern L, et al. Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment
with plasma infusion. Am J Kidney Dis 1985; 6:154.
Clasificacin
Gonzalez-Crespo MR, Lopez-Fernandez JI, Usera G, et al. Outcome of silent lupus nephritis. Semin Arthritis Rheum 1996; 26:468
Espectro clnico de la
nefritis
lpica
Sd. Nefrtico:
GN aguda:
proteinuria > 3 g/d
hypoalbuminemia
hyperlipidemia
Sedimento urinario
variable
Nefritis Lpica
RPGN:
Sedimento urinario
activo
Proteinuria
Hipertensin arterial
Crescents
Microangiopata
trombtica:
PTT / SHU
Sd. Antifosfolpido
TVR
Sedimento
urinario activo:
Hematuria
Piuria estril
Proteinuria
Cilindros
Marcadores bioqumicos
Brad H. Rovin et al; Biomarkers for Lupus Nephritis: The Quest Continues; Clin J Am Soc Nephrol
Nuevos marcadores
bioqumicos
Estudios
recientes de tipo
prospectivo estn tratando de
identificar nuevos marcadores que
puedan predecir el curso clnico de la
NL.
Se
renales.
Marcadores que anticipan el desarrollo
Brad H. Rovin et al; Biomarkers for Lupus Nephritis: The Quest Continues; Clin J Am Soc Nephrol
Nuevos marcadores
bioqumicos
Brad H. Rovin et al; Biomarkers for Lupus Nephritis: The Quest Continues; Clin J Am Soc Nephrol
Diagnstico
El
La
La
Geoffrey R. Bihl, Michelle Petri and Derek M. Fine. Kidney biopsy in lupus nephritis: look before you leap. Nephrol Dial Transplant
(2006) 21: 1749-1752
Diagnstico
Geoffrey R. Bihl, Michelle Petri and Derek M. Fine. Kidney biopsy in lupus nephritis: look before you leap. Nephrol Dial Transplant
(2006) 21: 1749-1752
Diagnstico
Los
Geoffrey R. Bihl, Michelle Petri and Derek M. Fine. Kidney biopsy in lupus nephritis: look before you leap. Nephrol Dial Transplant
(2006) 21: 1749-1752
Factores pronsticos
El
Se
Sara M. Mariani, MD, PhD. Conference report Lupus Nephritis: diagnosis, therapy, and outcomes. Highlights of the 7th
International Congress on SLE and Related Conditions; May 9-13, 2004; New York, NY.
Factores de mal
pronsticos
Sara M. Mariani, MD, PhD. Conference report Lupus Nephritis: diagnosis, therapy, and outcomes. Highlights of the 7th
International Congress on SLE and Related Conditions; May 9-13, 2004; New York, NY.
Factores de mal
pronsticos
Sara M. Mariani, MD, PhD. Conference report Lupus Nephritis: diagnosis, therapy, and outcomes. Highlights of the 7th
International Congress on SLE and Related Conditions; May 9-13, 2004; New York, NY.
Factores de mal
pronsticos
Sara M. Mariani, MD, PhD. Conference report Lupus Nephritis: diagnosis, therapy, and outcomes. Highlights of the 7th
International Congress on SLE and Related Conditions; May 9-13, 2004; New York, NY.
Factores de mal
pronsticos
Sara M. Mariani, MD, PhD. Conference report Lupus Nephritis: diagnosis, therapy, and outcomes. Highlights of the 7th
International Congress on SLE and Related Conditions; May 9-13, 2004; New York, NY.
Estratificacin segn
severidad de la enfermedad
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Tratamiento
Jan J. Weening, Vvette D. DAgati, Melvin M. Schwartz et al. The classification of glomerulonephritis in systemic
lupus erythematosus revisited. Kidney Int., Vol- 65 (2007) pp. 521-530
Tratamiento
NL
NL
Jan J. Weening, Vvette D. DAgati, Melvin M. Schwartz et al. The classification of glomerulonephritis in systemic
lupus erythematosus revisited. Kidney Int., Vol- 65 (2007) pp. 521-530
Tratamiento
NL
NL
Tratamiento
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Tratamiento
Terapia
de induccin:
Tratamiento
En
Desde
Austin HA III, Klippel JH, Balow JE, et al. Therapy of lupu nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl
Su
Compar
En
ARTHRITIS & RHEUMATISMVol. 46, No. 8, August 2002, pp 21212131 DOI 10.1002/art.10461 2002, American
No
Los
ARTHRITIS & RHEUMATISMVol. 46, No. 8, August 2002, pp 21212131 DOI 10.1002/art.10461 2002, American
Estudio
370
MMF
Ambos
mg/d.
Am Soc Nephrol 20: 11031112, 2009. doi: 10.1681/ASN.2008101028
El
Fall
Sin
Posteriores
Ambos
Se
El
Tratamiento
Terapia
de mantenimiento:
59
Recibieron
Se
La
El
Contreras G, Pardo V, Leclercq B et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350: 971
Opciones teraputicas en NL
refractaria
Rituximab:
Segn la evidencia acumulada, rituximab es
Opciones teraputicas en NL
refractaria
Inhibidores
de calcineurina:
Ciclosporina:
La eficacia y la seguridad de la ciclosporina en el tratamiento
de la NL proliferativa han sido demostrada en estudios abiertos
no controlados.
Es difcil titular su dosis en pacientes con deterioro de la
funcin renal.
Tacrlimus:
En un estudio abierto de nueve pacientes con NL proliferativa
difusa tratados con tacrlimus como terapia de induccin (0,1
mg/kg/da por dos meses, titulados hasta 0,06 mg/kg/da) ms
prednisona, se obtuvo respuesta renal completa en seis
pacientes (67%) y parcial en dos (22%)
Mok CC, Tong KH, To CH, Siu YP, Au TC. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot
study. Kidney Int 2005
Opciones teraputicas en NL
refractaria
Gamaglobulina
hiperinmune IV
(IGIV):
La IGIV se ha utilizado como terapia de
Opciones teraputicas en NL
refractaria
Plasmafresis:
En un estudio aleatorizado controlado, la
Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis.The Lupus
Algoritmo de
tratamiento
M. Waldman and GB Appel. Update on the treatment of lupus nephritis. Kidney International (2006) 70,1403-1412.
Tratamiento de NL
membranosa
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Evaluacin del
tratamiento
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Evaluacin del
tratamiento
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Cuando suspender el
tratamiento?
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Tratamiento coadjuvante
Dimitrios T. Boumpas, Prodromos Sidiropoulos and George Bertsias. Optimum therapeutic approaches for lupus nephritis:
what therapy and for whom? Nature Clinical Practice Rheumatology, November 2005 vol 1 N 1.
Gracias